Dopaminergic supersensitivity after neuroleptics: time-course and specificity
- PMID: 32574
- DOI: 10.1007/BF00429171
Dopaminergic supersensitivity after neuroleptics: time-course and specificity
Abstract
It is known that a single dose of a neuroleptic can elicit dopaminergic supersensitivity in animals. On the other hand, the clinical syndrome of tardive dyskinesia takes many months of years to develop. To resolve this apparent discrepancy, it is possible that subclinical or latent tardive dyskinesia is fully compensated in most patients taking neuroleptics. In others, where the tardive dyskinesia is full-blown and grossly apparent, the dopaminergic supersensitivity may be decompensated. Such compensatory and decompensatory phases have been proposed earlier by Hornykiewicz (1974), in the case of Parkinson's Disease. Dopaminergic supersensitivity persists for a period proportional to the lenght of the neuroleptic treatment. It is not yet clear whether the relation between the length of treatment and the persistence of supersensitivity holds for very long treatments, but in principle the relationship might account for the persistence of tardive dyskinesia after years of neuroleptic pretreatment.
Similar articles
-
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.Am J Psychiatry. 1980 Jan;137(1):16-21. doi: 10.1176/ajp.137.1.16. Am J Psychiatry. 1980. PMID: 6101522
-
An update on tardive dyskinesia.Hosp Community Psychiatry. 1986 Apr;37(4):362-9. doi: 10.1176/ps.37.4.362. Hosp Community Psychiatry. 1986. PMID: 2870977
-
Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.Am J Psychiatry. 1998 Sep;155(9):1207-13. doi: 10.1176/ajp.155.9.1207. Am J Psychiatry. 1998. PMID: 9734544
-
Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?J Clin Psychiatry. 1981 Dec;42(12):455-7. J Clin Psychiatry. 1981. PMID: 6118358 Review.
-
Iron modulates neuroleptic-induced effects related to the dopaminergic system.Isr J Med Sci. 1993 Sep;29(9):587-92. Isr J Med Sci. 1993. PMID: 7901181 Review.
Cited by
-
Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.Psychopharmacology (Berl). 1990;101(4):519-24. doi: 10.1007/BF02244231. Psychopharmacology (Berl). 1990. PMID: 2388975
-
Reduction of dopaminergic supersensitivity by a single dose of amphetamine.Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):131-3. doi: 10.1007/BF00498568. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6106902
-
Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference.Neuropharmacology. 2020 Nov 15;179:108276. doi: 10.1016/j.neuropharm.2020.108276. Epub 2020 Aug 16. Neuropharmacology. 2020. PMID: 32814089 Free PMC article.
-
Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.Psychopharmacology (Berl). 1989;98(3):386-91. doi: 10.1007/BF00451692. Psychopharmacology (Berl). 1989. PMID: 2568659
-
Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.Neurochem Res. 1985 Apr;10(4):491-8. doi: 10.1007/BF00964653. Neurochem Res. 1985. PMID: 2582289
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources